Canada approves 1st take-home psilocybin trial
A Vancouver-based pharmaceutical company will run the first take-home psilocybin clinical trial in North America.
Source: bc.ctvnews.ca
Page 38 - Special Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Special Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Special Access Program Today - Breaking & Trending Today
PMPRB finds ultra-rare drug PROCYSBI is excessively priced | Smart & Biggar
On September 1, 2022, a Panel of the Patented Medicine Prices Review Board (PMPRB) issued a decision that the price of Horizon Pharma’s PROCYSBI (cysteamine delayed release capsules)...
Source: jdsupra.com
Research, remedy and regulation: the changing dynamics of psychedelic therapy in Alberta
Earlier this month, Alberta announced new regulations for the use of psychedelics in therapy. Researchers and health-care professionals are increasingly exploring how drugs like ketamine can be used for mental health treatment.
Source: cbc.ca
A next-gen digital backbone will give U.S. platforms a one-versus-many advantage against near-peers
While the National Defense Authorization Act (NDAA) defined “open systems” at a high-level, each branch of the U.S. military is determining what that means for them. Collins Aerospace Mosarc™ solutions can address that across next-gen systems like NGAD, FVL, and KC-X.
Source: breakingdefense.com
Numinus Wellness Inc develops psilocybin-infused tea bag for use in psychedelic research
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has developed a tea bag containing psilocybin for use in clinical research and, if the...
Source: proactiveinvestors.com